News

Lung cancer is the number one cause of cancer-related death in the United States—and diagnosing the disease early is critical in improving survival rates.

Firearms have the power to change lives in an instant. Edward Overstreet carries that truth with him every day.

Alexis Ellington has a renewed outlook on life after being the first Saint Luke's patient to receive a new cancer treatment called Bispecific T-cell Engagers therapy, or BiTE.

We are talking about lung cancer and how precision oncology helps patients diagnosed with the disease with treatment.

Over the years, they have done everything together: graduated high school, tied the knot, bought their first home, and raised a family. For all they have shared, they never dreamed of sharing a cancer diagnosis.